Our R&D Programs

Bioneer’s research strategy addresses novel solutions for drug discovery and development that fulfil future needs of companies, research institutes, and Health Care.

Our Partners

To be successful in developing a drug candidate, mode of action patterns needs to be resolved, therapeutic modalities needs to be tailored to provide optimal treatment and therapeutic outcomes have to be monitored.

We strive to develop “best in class” solutions and are currently

running two ambitious R&D programs within:

  • In Vitro Models Assay & Development
  • Drug Candidate Development & Formulation

For further information, please contact CSO Christian Clausen by email or CBO Jette Asboe Lassen by email.

To be successful in developing a drug candidate, mode of action patterns needs to be resolved, therapeutic modalities needs to be tailored to provide optimal treatment and therapeutic outcomes have to be monitored.

We strive to develop “best in class” solutions and are currently running two ambitious R&D programs within:

  • In Vitro Models Assay & Development
  • Drug Candidate Development & Formulation

For further information, please contact CSO Christian Clausen by email or CBO Jette Asboe Lassen by email.

We have extensive experience working with all aspects of in vitro modelling, with focus on the following areas: CNS, Cancer, Gene Editing, Immunology and Gastro-Intestinal.

We have for decades developed and produced recombinant proteins, and developed formulation technology and principles for both small molecules and biologics.

We actively seek strategic collaboration opportunities with companies and academic institutions to complement and enhance the current applied research and service knowhow.

We have extensive experience working with all aspects of In Vitro modelling.

We have for decades developed and produced recombinant proteins, and developed formulation technology and principles for both small molecules and biologics.

We actively seek strategic collaboration opportunities with companies and academic institutions to complement and enhance the current applied research and service knowhow.

Latest news

Discover and read our latest news.

Read more